Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Dosing Interruption News

Dosing Interruption News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dosing Interruption. Real-time updates on events, politics, business and more.

Eisai : FDA Approves LEQEMBI™ (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's DiseaseAccelerated Approval is based on Phase 2 data showing a reduction in amyloid-beta plaques in early AD patients treated with LEQEMBI™ Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials

January 6, 2023
FDA Approves LEQEMBI™ Under the Accelerated Approval Pathway for the Treatment of Alzheimers Disease Accelerated Approval is based... | January 6, 2023
United Kingdom New Zealand United States Haruo Naito Christophera Viehbacher Natacha Gassenbach
Source: marketscreener.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science